Table 2 Reform measures which were of great concern to directors
From: Public hospital reforms in China: the perspective of hospital directors
Policies | Specific Measures | Total N = 178 | Director N = 87 | Associate Director N = 91 | ||||
|---|---|---|---|---|---|---|---|---|
Rank | No.(%) | Rank | No.(%) | Rank | No.(%) | p (X2) | ||
(I) | Increasing subsidies | 1 | 149 (83.7) | 1 | 72 (82.8) | 1 | 77 (84.6) | 0.737(0.112) |
(II) | Adjusting pricing policies | 3 | 127 (71.4) | 2 | 65 (74.7) | 4 | 62 (68.1) | 0.398(0.713) |
Removing drug mark-ups | 4 | 109 (61.2) | 5 | 45 (51.7) | 3 | 64 (70.3) | 0.011(6.486) | |
(III) | Reforming payment methods such as DRGs, capitation and global budgets | 6 | 78 (43.8) | 6 | 42 (48.3) | 6 | 36 (39.6) | 0.241(1.372) |
(IV) | Reform of personnel affairs and payroll distribution | 2 | 135 (75.8) | 3 | 62 (71.3) | 2 | 73 (80.2) | 0.163(1.947) |
Clarifying power and responsibility of public hospital directors | 5 | 103 (57.9) | 4 | 58 (66.7) | 5 | 45 (49.5) | 0.020(5.407) | |
(V) | Intensifying the government supervision | 7 | 59 (33.1) | 7 | 24 (27.6) | 7 | 35 (38.5) | 0.123(2.374) |
(VI) | Implementing clinical pathways | 8 | 34 (19.7) | 8 | 20 (21.8) | 8 | 14 (17.6) | 0.197(1.664) |